Gut Microbiome Alteration in HIV/AIDS and the Role of Antiretroviral Therapy—A Scoping Review
Microorganisms · 01.11.2024 · 12 (11) · 2221
DOI: 10.3390/microorganisms12112221 ↗Kurz gefasst
Scoping Review in der Zeitschrift Microorganisms, online erschienen am 01.11.2024. Verfasst von Zsófia Gáspár und 3 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Hematology and Infectious Diseases, Central Hospital of Southern Pest, H-1097 Budapest, Hungary. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: János Bolyai Research Scholarship of the Hungarian Academy of Sciences, “OTKA” Postdoctoral Excellence Programme 2023 of the National Research, Development, and Innovation Office of Hungary.
Abstract (Originalsprache)
(1)
Background
The gut microbiota plays a crucial role in chronic immune activation associated with human immunodeficiency virus (HIV) infection, acquired immune deficiency syndrome (AIDS) pathogenesis, non-AIDS-related comorbidities, and mortality among people living with HIV (PLWH). The effects of antiretroviral therapy on the microbiome remain underexplored. This study aims to map the evidence of the impact of integrase strand transfer inhibitors (INSTI) and non-nucleoside reverse transcriptase inhibitors (NNRTI) on the gut microbiota of PLWH. (2)
Methods
A scoping review was conducted using PubMed, Web of Science, and Embase, with reports collected following PRISMA for Scoping Reviews (PRISMA-ScR). (3)
Results
Evidence suggests that INSTI-based regimes generally promote the restoration of alpha diversity, bringing it closer to that of seronegative controls, while beta diversity remains largely unchanged. INSTI-based therapies are suggested to be associated with improvements in microbiota composition and a tendency toward reduced inflammatory markers. In contrast, NNRTI-based treatments demonstrate limited recovery of alpha diversity and are linked to an increase in proinflammatory bacteria. (4)
Conclusions
Based on the review of the current literature, it is indicated that INSTI-based antiretroviral therapy (ART) therapy facilitates better recovery of the gut microbiome.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Institute of Hematology and Infectious Diseases, Central Hospital of Southern Pest, H-1097 Budapest, Hungary.
- Doctoral School of Clinical Medicine, Semmelweis University, H-1097 Budapest, Hungary.
- Departmental Group of Infectious Diseases, Department of Internal Medicine and Hematology, Semmelweis University, H-1097 Budapest, Hungary.
ORCID-Profile: Bálint Gergely Szabó
Förderung
- János Bolyai Research Scholarship of the Hungarian Academy of Sciences
- “OTKA” Postdoctoral Excellence Programme 2023 of the National Research, Development, and Innovation Office of Hungary
Zitieren
APA
Gáspár, Z., Nagavci, B., Szabó, B. G., & Lakatos, B. (2024). Gut Microbiome Alteration in HIV/AIDS and the Role of Antiretroviral Therapy—A Scoping Review. Microorganisms, 12(11), 2221. https://doi.org/10.3390/microorganisms12112221
Vancouver
Gáspár Z, Nagavci B, Szabó BG, Lakatos B. Gut Microbiome Alteration in HIV/AIDS and the Role of Antiretroviral Therapy—A Scoping Review. Microorganisms. 2024;12(11):2221. doi:10.3390/microorganisms12112221
BibTeX
@article{Gspr2024,
author = {Gáspár, Zsófia and Nagavci, Blin and Szabó, Bálint Gergely and Lakatos, Botond},
title = {Gut Microbiome Alteration in HIV/AIDS and the Role of Antiretroviral Therapy—A Scoping Review},
journal = {Microorganisms},
year = {2024},
volume = {12},
number = {11},
pages = {2221},
doi = {10.3390/microorganisms12112221}
}
EUVIMED